SMA patients across the country became agitated on this day.

When Sanqing released clinical trial announcements before, many parents did not apply immediately for one reason or another.

Some of them have fairly good families and have already used Bogen's Nosinaxin Sodium Injection, and their children have temporarily improved, so there is no need to worry.

Some people have doubts and want to see the results of clinical trials before commenting.

Some of them are too far away from Kunming City and cannot be reached in a short time.

In short, there are many, and most people have not had time to apply, and the first clinical phase has ended.

At this moment, when they saw the recovery photos of children with experimental diseases posted or reposted by group friends.

I couldn't sit still for a moment.

"Nini's mother, tell me what are the requirements for this application?"

"Yes, how long did it take for your child to be cured?"

"Is it really just one shot? Just give it a shot?"

"That's great. My baby is finally saved. I will apply immediately."

Nini’s mother patiently replied one by one.

"The requirements are not high, just bring the case and talk about the basic situation."

"It took a day to do the examination, and then the injections. After waiting in the ward for about three days, Nini was able to breathe and eat. She sat up the next day, and after a few days she was able to stand up."

"Anyway, it's really miraculous. It's like a miracle medicine! You should hurry up and apply. The sooner you experiment, the sooner you'll be better!"

Nini’s mother’s words were full of joy, and she shared all her experiences in clinical trials from the bottom of her heart.

The parents were all very excited when they saw it.

Those who were close immediately left for Kunming, and those who were far away immediately called to inquire about the registration status.

"Hey, hello, is this Sanqing Pharmaceutical? I am the parent of a child with spinal muscular atrophy. I would like to ask how to apply for a clinical trial?"

"Hello, thank you for your call. The current number of people in the second phase of clinical trials for this disease is 300. Sorry, they are all full. You can register your information and apply for the third phase of clinical trials. We will contact you in advance when the time comes.

Yours." The voice on the other end of the phone was very sweet.

"Ah? The registration is full so quickly?" The parents were immediately disappointed. After thinking about it, they continued to ask: "How many people are needed for the three phases?"

"The specific number of people for the third phase has not yet been determined. According to convention, there should be thousands of people."

"Okay, then just give me your registration information now and I'll sign up right away."

Scenes like this keep happening, and the list of clinical trial applications is getting longer and longer.

Since there are relatively few patients with rare diseases, the number of people required for clinical trials is also lower than for common diseases.

SMA is already considered a rare disease with a large number of patients, with tens of thousands of patients at least, so it is not difficult to find patients.

Some diseases only affect hundreds of people worldwide and only dozens of people in China. It is extremely difficult to find patients.

This time, only 1,000 people are enough for the Phase III clinical trial of SMA, and the total number of people in all clinical trials is 1,330.

Therefore, the quota for the third phase of clinical trials was soon filled up.

Some people are overjoyed when their application is successful.

Some people are a few steps late and miss the opportunity. They can only continue to wait for phase 4 clinical trials or for the drug to be launched.

******

One month after the clinical trial, Sanqing Group held a press conference.

Officially announced the success of the spinal muscular atrophy (SMA) gene therapy drug, and presented the experimental reports of the first and second phases of clinical trials.

As soon as the news came out, the entire media went into a frenzy!

Both domestic and foreign reporters’ faces turned red with excitement.

"Mr. Wei, are Sanqing going to launch an attack on the field of gene therapy for rare diseases?"

"That's right. The success of this SMA gene drug not only means that SMA patients can escape the sea of ​​suffering, but also shows that our company has the strength to make great strides in the field of gene therapy."

Wei Kang proudly announced: "As we all know, 80% of rare diseases are single-gene genetic diseases, and gene therapy is the fastest way to cure them. In the past, we could only do nothing when facing these diseases, or adopt some methods that treated the symptoms but not the root cause.

, and now, humans have sufficient technical means to save more patients with rare diseases."

"We will continue to use gene therapy to conquer other rare diseases, please wait and see!"

The scene burst into thunderous applause.

After the press conference, many Chinese and foreign reporters immediately wrote news reports with great excitement and couldn't wait to post them online.

Some reporters even left the venue and started writing directly in the car on the way back.

"Sanqing officially announced that it has conquered spinal muscular atrophy (SMA) and declared war on other rare diseases."

grasshopper

"Wei Kang, a god-like man, once again created a miracle."

"We have witnessed the real rise of China's pharmaceutical industry, and Sanqing may become a global medical leader."

"With everything that man has to say, what other surprises will he bring to us?"

"As Sanqing continues to overcome medical problems one after another, we are witnessing a new era."

After seeing the news, netizens were all excited.

"Mr. Wei is awesome, he actually did it."

"Although rare diseases are not common around us, they are extremely painful conditions for patients and their families. Sanqing does not research and develop public diseases, but focuses on the field of rare diseases. This is true compassion and an unparalleled national scholar!"

"Wow, great love has no boundaries, I'm so moved that I want to cry!"

"Sanqing has once again saved tens of thousands of patients and families across the country!"

"This is the patron saint of China. As long as we have Sanqing, we will no longer have to take exorbitantly expensive imported medicines!"

On the other side, the SMA family members also shed tears of excitement.

They didn't know how many hospitals they went to, how many doctors they consulted, and they traveled all over the country.

Neither will get good results.

I can only watch the children step by step towards the abyss of serious illness and death.

In the beginning, this disease was terminal and there was no cure!

Later, finally there was medicine.

But they are all imported high-priced medicines, and the prices are so high that they are out of reach!

But starting today.

China also has its own domestically produced medicines.

It is no longer a terminal disease in human medicine, and there are treatments within reach.

And the person who gives them hope.

It’s Wei Kang.

For a time, countless SMA family members silently erected a monument for Wei Kang in their hearts.

******

The Eagle Country far across the ocean.

The headquarters of Novartis Pharmaceuticals, where the world's top experts in the field of gene therapy gather.

At this moment, watching the news on the big screen, all the executives and experts were silent.

Their faces were as ugly as those of dead people.

"It's over, the company's stock price is about to drop to the limit again." The CEO turned pale and muttered to himself.

"Are we going to cut prices?" an expert couldn't help but ask.

Senior executives, you looked at me, I looked at you, but no one said anything.

For a long time, the Novartis CEO waved his hand with difficulty: "Of course the price will be reduced, but how much the price will be reduced depends on the decision of the board of directors."

"If you think about it better, at least our SMA gene drug has been purchased for 1 billion U.S. dollars. In fact, it has already paid back its capital, and any subsequent sales will be pure profits." The CFO reminded kindly.

Everyone looked depressed and smiled bitterly.

When things come to this, it can only be like this.

The same scene also happened with Bogen and Roche.

The next day, the stock prices of these three pharmaceutical companies fell sharply at the same time, with their stock prices falling by 20%.

And they all announced price cuts, starting from 50%.

The era of huge profits from SMA drugs has just disappeared.

It was as fast as flying, catching everyone off guard.

The news spread to the country.

Whether it is netizens or parents of children with SMA.

While looking forward to the launch of Sanqing’s new SMA drug.
Chapter completed!